Preliminary report of late recurrences, at 5 years or more, after stereotactic body radiation therapy for non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 7, Issue 2, 2012, Pages 453-456

  Matsuo, Yukinori ^a   Shibuya, Keiko ^a   Nagata, Yasushi ^b   Norihisa, Yoshiki ^a   Narabayashi, Masaru ^a   Sakanaka, Katsuyuki ^a   Ueki, Nami ^a   Mizowaki, Takashi ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Late recurrence; Non small cell lung cancer; Stereotactic body radiation therapy

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 84858317146     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31823c5b29     Document Type: Article

References (10)

1. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-1076.
2. Nagata Y, Hiraoka M, Shibata T, et al. A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403). Int J Radiat Oncol Biol Phys 2010;78:S27-S28.
3. Takayama K, Nagata Y, Negoro Y, et al. Treatment planning of stereotactic radiotherapy for solitary lung tumor. Int J Radiat Oncol Biol Phys 2005;61:1565-1571. (Pubitemid 40470441)
4. Hiraoka M, Matsuo Y, Takayama K. Stereotactic body radiation therapy for lung cancer: achievements and perspectives. Jpn J Clin Oncol 2010;40:846-854.
5. Matsuo Y, Shibuya K, Nagata Y, et al. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011;79:1104-1111.
6. Thomas PA, Rubinstein L. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. The Lung Cancer Study Group. J Thorac Cardiovasc Surg 1993;106:1053-1058. (Pubitemid 24018548)
7. Pasini F, Pelosi G, Valduga F, et al. Late events and clinical prognostic factors in stage I non small cell lung cancer. Lung Cancer 2002;37:171-177. (Pubitemid 34831809)
8. Maeda R, Yoshida J, Ishii G, et al. Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer. J Thorac Oncol 2010;5:1246-1250.
9. Matsuo Y, Nagata Y, Mizowaki T, et al. Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol 2007;12:356-362. (Pubitemid 47573413)
10. Matsuo Y, Nakamoto Y, Nagata Y, et al. Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer. Radiother Oncol 2010;97:200-204.